Research Topic · Peer-Reviewed

Pluripotent

Pluripotent cells are stem cells capable of differentiating into derivatives of all three embryonic germ layers, the endoderm, mesoderm, and ectoderm, while retaining the capacity for prolonged self-renewal. This developmental potency distinguishes them from multipotent progenitors, which are restricted to a single …

Curated from this journal's research 📚 8 peer-reviewed articles cited Cited 35× across the literature 🔖 ISSN 2574-4372 🗓 Reviewed July 2026

Overview

Pluripotent cells are stem cells capable of differentiating into derivatives of all three embryonic germ layers, the endoderm, mesoderm, and ectoderm, while retaining the capacity for prolonged self-renewal. This developmental potency distinguishes them from multipotent progenitors, which are restricted to a single lineage, and from totipotent zygotes, which can additionally form extraembryonic tissue. Pluripotency is maintained by a core transcriptional network centred on factors such as OCT4, SOX2, and NANOG, and its regulation can be modulated post-transcriptionally, including by microRNAs that target the promoters and transcripts of these master genes. Pluripotent populations include embryonic stem cells and induced pluripotent stem cells, the latter generated by reprogramming somatic cells. Their unrestricted differentiation makes them central to regenerative medicine and disease modelling: pluripotent-derived cardiomyocytes support calcium-transient and contractility assays for compound screening and preclinical cardiotoxicity testing, and pluripotent-derived neural cells seeded onto biocompatible three-dimensional scaffolds are used to model tissue repair such as post-stroke recovery. Realising these applications requires attention to directed differentiation efficiency, genomic stability, lineage purity, and the ethical frameworks governing stem cell sourcing and therapeutic translation. Research in this area spans the molecular control of the pluripotent state, in vitro models of human physiology, and emerging cell-based therapeutic strategies.

Research published in this journal

8 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 8 articles above have been cited 35 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Pluripotent, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Evolving Stem Cell Research (ISSN 2574-4372).

Journal editorial board
Takafumi Yokota · Japan Chiara Raggi · Italy Morikuni Tobita · Japan

This page summarises published research for orientation; it is not medical or professional advice.